The 2018 two-vote system must be launched nationwide, and equipment supplies are also implemented!

Medical Network March 22 News National six ministries jointly issued a document explicitly requested that in 2018 the two-vote system must be implemented throughout the country! Instrument consumables must also be fully implemented!

Do not think that the Medical Reform Office will withdraw, and the two-vote system will stop. Do not assume that the implementation of the two-vote system will reduce the implementation of institutional reforms. Do not assume that two years of high-value consumables and two-vote systems have not changed for two years. Advance!

On March 20, the official website of the National Health and Planning Commission published the Notice on Consolidating the Achievements of Breaking Out the Medicine and Supplementing the Medical Care and Deepening the Comprehensive Reform of Public Hospitals (Guowei Shifa [2018] No. 4).

The "Notice" was issued jointly by the National Health and Family Planning Commission, the Ministry of Finance, the Ministry of Human Resources and Social Sciences, the National Development and Reform Commission, the Chinese Medicine Administration, and the Medical Reform Office. It set the key areas and key links for deepening medical reform in 2018 and beyond, and fully emphasized the implementation.

This will not only further implement the spirit of the several documents issued by the State Department in connection with medical reforms in the past two years, but also implement the 2018 work proposal put forward by the Premier of the State Council on March 5 this year in the government work report, including: Deepening the comprehensive reform of public hospitals. , Coordinate the promotion of medical prices, personnel remuneration, drug distribution, medical insurance payment reform, improve the quality of medical and health services, and make great efforts to solve the problem of medical treatment.

The notification pointed out that in 2018, all provinces would implement the “two-vote system” plan for the purchase and sale of pharmaceuticals. This shows that although the organization has been reformed, the organization has been reorganized, and the Medical Reform Office has withdrawn. enterprise Institutions at all levels must not have illusions and wait and see if they are implemented. They still need to be strictly enforced.

The notice proposes to promote data sharing, linking illegal clues, interoperability of regulatory standards, and mutual recognition of processing results. This shows that the two-vote system in 2018 is not just a full-scale implementation, but also strictly handles violations, 'data sharing, illegal links ' Means that companies rely on opportunism, wielding the ball and stepping on the line will not work, 'regulatory standards interoperability, mutual recognition of processing results' means that violations will occur in one place and will be implicated elsewhere.

The two-vote system is undoubtedly a very important policy directly affecting the pharmaceutical industry in the past two years. Since the implementation of the two-vote system on April 6, 2016, the State Council has repeatedly proposed the implementation of a two-vote system for drugs. :

In November 2016, the "State Council Deepening the Several Opinions of the Leading Group for Medical and Health System Reform Leading Group on Further Promoting the Experience in Deepening the Reform of Medical and Health System" was released, hospital Drug procurement is gradually implemented two votes system.

On January 9, 2017, the State Council’s “13th Five-Year Plan for Deepening Medical and Health Care System Reform” proposed the implementation of the reform of the “two-vote system” for drug procurement, and clarified the pilot provinces (autonomous regions, municipalities) and public hospital reform pilot cities for comprehensive medical reforms. Public medical institutions must take the lead in promoting the 'two-vote system' for drug procurement and encourage other regions to implement the 'two-vote system'.

On February 9, 2017, the State Council’s General Office of the People’s Republic of China issued a “Some Opinions on Further Reforming and Perfecting the Drug Production, Distribution, and Use Policy” further proposed to rectify the order of drug circulation, promote the reform of the pharmaceutical distribution system, and implement the 'two-vote system' for drug purchases and sales.

At this point, the two-vote system advanced rapidly. By the end of October 2017, all provinces across the country had proposed a timetable for implementing the two-vote system.

Since then, the implementation of the landing has become the key. The notice just released by the six departments is a document that requires implementation and highlights the 'promotion of data sharing, interconnection of illegal leads, regulatory standards interoperability, mutual recognition of processing results', etc. This is not only a request to the competent authority but also indirect involvement of the company.

The "Notice" also pointed out that in 2018, high-value consumables will be gradually implemented with a two-vote system.

This is also after the 9 points issued by the ministries and commissions in the "Correction of Corrective Treatment of Irregularity in Medical Purchases and Marketing and Medical Services in 2016". It is proposed that after implementing the "two-vote system" for consumables in the pilot cities and pilot cities for medical reform, the national font file will be proposed again. To implement the 'two-vote system'.

In the past two years, the state raised the 'two-vote system' and issued a notice in the name of 'National Health Reform'. This means that the 'two-vote system' for consumables will be widely pushed across the country since this year. After the drug, the supplies 'two-vote system' board nailed!

In combination with the “notice” content, the comprehensive reform of public hospitals in the national model cities, demonstration counties (cities, districts, and flags) shall intensify reforms, first try in key areas and key links, and be the first to break through. ', high value consumables' The gradual implementation of the 'ticket system' is to be implemented first in the medical reform model cities and demonstration counties.

Up to now, the state has published a total of a list of national model cities, a list of two national demonstration counties, a total of 15 cities and 30 counties.

In the past few years, medical control fees have been an important reform measure in the national medical reform. This includes the elimination of drug additions, the proportion of drug consumption control, and the implementation of cost control through Medicare payment reform.

Among them, cancellation of drug additions has been achieved nationwide by the end of September last year, and the proportion of reduced drugs has been hotly promoted. In order to complete the targets, various localities have formulated the 'Key Drug Surveillance Catalogue' to monitor not only the use of drugs, but also the monitoring of dosages. Large pharmaceuticals and consumables have caused many drug companies to be under heavy pressure, and some 'heavy drugs' sales have fallen significantly.

In 2018, according to the notice issued by the six departments, the control fee will surely continue. Strict control will not relax.

In the case of Medicare payments, the notification document is to implement the “Guidance Opinions on Further Deepening the Reform of Payment Methods for Basic Medical Insurance” of the State Council (Guobanfa [2017] No. 55) 'to fully implement multivariate focusing on disease-based payment. Composite medical insurance payment methods' specific measures.

The document proposes that in 2018, the state will unify more than 100 disease types and guide local governments to promote implementation. Advancing DRG payment pilots to improve per-headcount, per-bed day and other payment methods. National Medical Insurance Bureau currently Has been established, the reform of health insurance management, medical prices, Bidding The supervisory functions of other industries will inevitably greatly accelerate the advancement of medical insurance payment reform.

At the same time, in the aspect of cost control, the notice also proposed the control indicators for the growth of medical expenses in provinces, prefectures, and counties. It is necessary to subdivide the control fee index into each hospital, and not to pursue 'one size fits all'. To set a control fee target, the meaning is also very clear: Look at your own pocketbook. The poor provinces should not compare with the rich areas. If you have no money, you can save some money.

In addition, the “Notice” also states that in 2018, the following important medical reforms need to be implemented throughout the country:

1. Indicators of reform and development are linked to financial subsidies, health insurance payments, salary levels and total payroll, salary, appointments and dismissals, rewards and punishments.

2. To continue to control the unreasonable growth of medical expenses, and 44 large administrative hospitals of the “national team” are also subject to control fees;

3. Strictly crack down on commercial bribery in the field of pharmaceutical purchase and sale, and resolutely correct unhealthy practices in the purchase, sale of medicines, and medical services.

4. The adjustment of medical service price and medical insurance payment, medical control fee, grading diagnosis and treatment and other policies are linked.

5, high-value consumables should explore the implementation of package fees, the development of a unified medical service price; the implementation of high-value medical supplies concentrating procurement.

The above reforms will also directly or indirectly affect pharmaceutical companies.